Antimicrobial resistance (AMR) is a leading global public health threat that calls for coordinated action across multiple sectors. In 2024, country representatives at the UN General Assembly committed to creating the Independent Panel on Evidence for Action against AMR (IPEA). This initiative is aimed to bring together multidisciplinary experts to provide countries with evidence-based guidance on how to effectively address AMR. The IPEA is set to be established by the end of 2025.
How will the IPEA provide solutions that are representative of AMR in low, middle, and high resource settings? What are some potential challenges that the IPEA may face in its development stage? What are the short and long-term priorities of the IPEA?
We discuss all of this and more in Episode 7 of Unpacking AMR, hosted by GSL Director of Communications Demetria Tsoutouras, who she speaks with Dr. Iruka Okeke, a Professor of Pharmaceutical Microbiology, and Anthony McDonnell, a Policy Fellow in the Center for Global Development’s Global Health Team. The development of the IPEA is a step forward in addressing the complex and wide spanning concern of AMR.
All content for Unpacking AMR is the property of AMR Policy Accelerator and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Antimicrobial resistance (AMR) is a leading global public health threat that calls for coordinated action across multiple sectors. In 2024, country representatives at the UN General Assembly committed to creating the Independent Panel on Evidence for Action against AMR (IPEA). This initiative is aimed to bring together multidisciplinary experts to provide countries with evidence-based guidance on how to effectively address AMR. The IPEA is set to be established by the end of 2025.
How will the IPEA provide solutions that are representative of AMR in low, middle, and high resource settings? What are some potential challenges that the IPEA may face in its development stage? What are the short and long-term priorities of the IPEA?
We discuss all of this and more in Episode 7 of Unpacking AMR, hosted by GSL Director of Communications Demetria Tsoutouras, who she speaks with Dr. Iruka Okeke, a Professor of Pharmaceutical Microbiology, and Anthony McDonnell, a Policy Fellow in the Center for Global Development’s Global Health Team. The development of the IPEA is a step forward in addressing the complex and wide spanning concern of AMR.
Antimicrobial resistance (AMR) is a leading global public health threat that calls for coordinated action across multiple sectors. In 2024, country representatives at the UN General Assembly committed to creating the Independent Panel on Evidence for Action against AMR (IPEA). This initiative is aimed to bring together multidisciplinary experts to provide countries with evidence-based guidance on how to effectively address AMR. The IPEA is set to be established by the end of 2025.
How will the IPEA provide solutions that are representative of AMR in low, middle, and high resource settings? What are some potential challenges that the IPEA may face in its development stage? What are the short and long-term priorities of the IPEA?
We discuss all of this and more in Episode 7 of Unpacking AMR, hosted by GSL Director of Communications Demetria Tsoutouras, who she speaks with Dr. Iruka Okeke, a Professor of Pharmaceutical Microbiology, and Anthony McDonnell, a Policy Fellow in the Center for Global Development’s Global Health Team. The development of the IPEA is a step forward in addressing the complex and wide spanning concern of AMR.
What does the way we build and live in cities have to do with the way bacteria resist antibiotics?
In this #UnpackingAMR episode, we explore a new perspective that helps us understand how urbanization, social inequities, infrastructure, and global systems contribute to the rise of AMR.
Join our host, Daniela Corno, and guests Dr. Raphael Aguiar and Dr. Kayla Strong as they dive into this concept.
New conceptions and perspectives are needed to challenge traditional antimicrobial resistance (AMR) narratives and create interdisciplinary solutions for policy impact.
Today’s conversation features Dr. Isaac Weldon (Cebil - University of Copenhagen) and Dr. Ilaria Natali (Toulouse School of Economics (TSE), exploring the socio-ecological dynamics of AMR. This perspective shifts the narrative from a war that we must win to understanding how humans and microbes co-exist.
This year, at the UN General Assembly High-Level Meeting on antimicrobial resistance (AMR), a major political declaration on AMR was adopted. But what happens next? It's time to turn commitments into action.
Intro Music: Elevator Pitch by Shane Ivers - www.silvermansound.com
In this episode of Unpacking AMR we explore the principles behind the SAFE AMR Governance Partnership. Join us in a conversation with Julianne Piper, Carly Ching, Isaac Weldon, and Jeremy Grimshaw while they highlight how a collaborative, One Health approach can help safeguard our global pool of antimicrobials for future generations.
Join us for a conversation with Dr. Susan Rogers Van Katwyk and Dr. Mathieu Poirier as we dive deeper into what antimicrobial resistance really means, how AMR expands beyond human health to animals and infrastructure, and some ways that researchers are currently working with a global, interdisciplinary approach to address this issue.
Intro Music: Elevator Pitch by Shane Ivers - https://www.silvermansound.com
Welcome to Unpacking AMR: It’s more than bugs and drugs!
Antimicrobial resistance occurs when bacteria, viruses, and other microbes stop responding to antimicrobial medicines. Unpacking AMR delves into the challenges of drug-resistant infections. Join the conversation on creating sustainable, fair, and evidence-informed policies. Remember, AMR is more than drugs and bugs!
Music credit: Elevator Pitch by Shane Ivers - https://www.silvermansound.com
Antimicrobial resistance (AMR) is a leading global public health threat that calls for coordinated action across multiple sectors. In 2024, country representatives at the UN General Assembly committed to creating the Independent Panel on Evidence for Action against AMR (IPEA). This initiative is aimed to bring together multidisciplinary experts to provide countries with evidence-based guidance on how to effectively address AMR. The IPEA is set to be established by the end of 2025.
How will the IPEA provide solutions that are representative of AMR in low, middle, and high resource settings? What are some potential challenges that the IPEA may face in its development stage? What are the short and long-term priorities of the IPEA?
We discuss all of this and more in Episode 7 of Unpacking AMR, hosted by GSL Director of Communications Demetria Tsoutouras, who she speaks with Dr. Iruka Okeke, a Professor of Pharmaceutical Microbiology, and Anthony McDonnell, a Policy Fellow in the Center for Global Development’s Global Health Team. The development of the IPEA is a step forward in addressing the complex and wide spanning concern of AMR.
